Literature DB >> 29744964

Peering into the HIV reservoir.

Marcial García1,2, María J Buzón3, José M Benito1,2, Norma Rallón1,2.   

Abstract

The main obstacle to HIV eradication is the establishment of a long-term persistent HIV reservoir. Although several therapeutic approaches have been developed to reduce and eventually eliminate the HIV reservoir, only a few have achieved promising results. A better knowledge of the mechanisms involved in the establishment and maintenance of HIV reservoir is of utmost relevance for the design of new therapeutic strategies aimed at purging it with the ultimate goal of achieving HIV eradication or alternatively a functional cure. In this regard, it is also important to take a close look into the cellular HIV reservoirs other than resting memory CD4 T-cells with key roles in reservoir maintenance that have been recently described. Unraveling the special characteristics of these HIV cellular compartments could aid us in designing new therapeutic strategies to deplete the latent HIV reservoir.
Copyright © 2018 John Wiley & Sons, Ltd.

Entities:  

Keywords:  HIV reservoir; T follicular helper cells; myeloid-derived cells; resting memory CD4 T cells; stem cell-like memory T cells

Mesh:

Substances:

Year:  2018        PMID: 29744964      PMCID: PMC6041174          DOI: 10.1002/rmv.1981

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN: 1052-9276            Impact factor:   6.989


  206 in total

1.  Balanced expression of CXCR5 and CCR7 on follicular T helper cells determines their transient positioning to lymph node follicles and is essential for efficient B-cell help.

Authors:  Svenja Hardtke; Lars Ohl; Reinhold Förster
Journal:  Blood       Date:  2005-05-17       Impact factor: 22.113

2.  The role of mononuclear phagocytes in HTLV-III/LAV infection.

Authors:  S Gartner; P Markovits; D M Markovitz; M H Kaplan; R C Gallo; M Popovic
Journal:  Science       Date:  1986-07-11       Impact factor: 47.728

Review 3.  Immunological strategies to target HIV persistence.

Authors:  Glòria Martrus; Marcus Altfeld
Journal:  Curr Opin HIV AIDS       Date:  2016-07       Impact factor: 4.283

Review 4.  Shocking HIV out of hiding: where are we with clinical trials of latency reversing agents?

Authors:  Thomas A Rasmussen; Sharon R Lewin
Journal:  Curr Opin HIV AIDS       Date:  2016-07       Impact factor: 4.283

Review 5.  Preclinical shock strategies to reactivate latent HIV-1: an update.

Authors:  Gilles Darcis; Benoît Van Driessche; Carine Van Lint
Journal:  Curr Opin HIV AIDS       Date:  2016-07       Impact factor: 4.283

6.  Orientation-dependent regulation of integrated HIV-1 expression by host gene transcriptional readthrough.

Authors:  Yefei Han; Yijie B Lin; Wenfeng An; Jie Xu; Hung-Chih Yang; Karen O'Connell; Dominic Dordai; Jef D Boeke; Janet D Siliciano; Robert F Siliciano
Journal:  Cell Host Microbe       Date:  2008-08-14       Impact factor: 21.023

7.  Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation.

Authors:  Hung-Chih Yang; Sifei Xing; Liang Shan; Karen O'Connell; Jason Dinoso; Anding Shen; Yan Zhou; Cynthia K Shrum; Yefei Han; Jun O Liu; Hao Zhang; Joseph B Margolick; Robert F Siliciano
Journal:  J Clin Invest       Date:  2009-10-01       Impact factor: 14.808

8.  HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation.

Authors:  Nicolas Chomont; Mohamed El-Far; Petronela Ancuta; Lydie Trautmann; Francesco A Procopio; Bader Yassine-Diab; Geneviève Boucher; Mohamed-Rachid Boulassel; Georges Ghattas; Jason M Brenchley; Timothy W Schacker; Brenna J Hill; Daniel C Douek; Jean-Pierre Routy; Elias K Haddad; Rafick-Pierre Sékaly
Journal:  Nat Med       Date:  2009-06-21       Impact factor: 53.440

9.  Human immunodeficiency virus infection of megakaryocytic cells.

Authors:  M Sakaguchi; T Sato; J E Groopman
Journal:  Blood       Date:  1991-02-01       Impact factor: 22.113

10.  Low SAMHD1 expression following T-cell activation and proliferation renders CD4+ T cells susceptible to HIV-1.

Authors:  Nicolas Ruffin; Vedran Brezar; Diana Ayinde; Cécile Lefebvre; Julian Schulze Zur Wiesch; Jan van Lunzen; Maximilian Bockhorn; Olivier Schwartz; Hakim Hocini; Jean-Daniel Lelievre; Jacques Banchereau; Yves Levy; Nabila Seddiki
Journal:  AIDS       Date:  2015-03-13       Impact factor: 4.177

View more
  9 in total

1.  Dynamics of HIV Reservoir and HIV-1 Viral Splicing in HCV-Exposed Individuals after Elimination with DAAs or Spontaneous Clearance.

Authors:  Paula Martínez-Román; Celia Crespo-Bermejo; Daniel Valle-Millares; Violeta Lara-Aguilar; Sonia Arca-Lafuente; Luz Martín-Carbonero; Pablo Ryan; Ignacio de Los Santos; María Rosa López-Huertas; Claudia Palladino; María Muñoz-Muñoz; Amanda Fernández-Rodríguez; Mayte Coiras; Verónica Briz
Journal:  J Clin Med       Date:  2022-06-21       Impact factor: 4.964

Review 2.  Tyrosine Kinase Inhibition: a New Perspective in the Fight against HIV.

Authors:  Sara Rodríguez-Mora; Adam M Spivak; Matthew A Szaniawski; María Rosa López-Huertas; José Alcamí; Vicente Planelles; Mayte Coiras
Journal:  Curr HIV/AIDS Rep       Date:  2019-10       Impact factor: 5.071

Review 3.  Platelets in HIV: A Guardian of Host Defence or Transient Reservoir of the Virus?

Authors:  Etheresia Pretorius
Journal:  Front Immunol       Date:  2021-04-23       Impact factor: 7.561

Review 4.  Microglial Cells: The Main HIV-1 Reservoir in the Brain.

Authors:  Clementine Wallet; Marco De Rovere; Jeanne Van Assche; Fadoua Daouad; Stéphane De Wit; Virginie Gautier; Patrick W G Mallon; Alessandro Marcello; Carine Van Lint; Olivier Rohr; Christian Schwartz
Journal:  Front Cell Infect Microbiol       Date:  2019-10-24       Impact factor: 5.293

5.  The Dual-Specificity Kinase DYRK1A Modulates the Levels of Cyclin L2 To Control HIV Replication in Macrophages.

Authors:  Javan K Kisaka; Lee Ratner; George B Kyei
Journal:  J Virol       Date:  2020-02-28       Impact factor: 5.103

Review 6.  Editing out HIV: application of gene editing technology to achieve functional cure.

Authors:  Jingna Xun; Xinyu Zhang; Shuyan Guo; Hongzhou Lu; Jun Chen
Journal:  Retrovirology       Date:  2021-12-18       Impact factor: 4.602

Review 7.  The reservoir of latent HIV.

Authors:  Jing Chen; Tong Zhou; Yuan Zhang; Shumin Luo; Huan Chen; Dexi Chen; Chuanyun Li; Weihua Li
Journal:  Front Cell Infect Microbiol       Date:  2022-07-28       Impact factor: 6.073

Review 8.  Are BET Inhibitors yet Promising Latency-Reversing Agents for HIV-1 Reactivation in AIDS Therapy?

Authors:  Thanarat Salahong; Christian Schwartz; Rungroch Sungthong
Journal:  Viruses       Date:  2021-05-29       Impact factor: 5.048

9.  Brain HIV-1 latently-infected reservoirs targeted by the suicide gene strategy.

Authors:  Clémentine Wallet; Christian Schwartz; Sepideh Saeb; Mehrdad Ravanshad; Mahmoud Reza Pourkarim; Fadoua Daouad; Kazem Baesi; Olivier Rohr
Journal:  Virol J       Date:  2021-05-31       Impact factor: 4.099

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.